A year ago the pandemic started to disrupt clinical research, resulting in the suspension of more than 2,000 trials over the course of 2020. It is heartening to discover that around half of these studies have resumed, a new analysis from Evaluate Vantage finds, an impressive statistic considering that Covid-19 is still causing huge global upheaval.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,